The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acquired | Acquired


X-SPRAYS is a brand of life-enhancement products administered via an optimal oral spray delivery system.

X-SPRAYS Headquarter Location


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest X-SPRAYS News

Integrated Cannabis Company, Inc. to Attend the Athens Cannabis Expo 2019

Jan 15, 2019

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis”), is excited to announce that X-SPRAYS™ successfully exhibited at the 2019 Athens Cannabis Expo in Greece last weekend at the Tae Kwon Do Convention Center in Athens, Greece. The Expo took place January 11-13 in Athens and attracted industry leaders from across the European Union (EU) and other parts of the globe. X-SPRAYS™ was on display and the company’s sales team successfully educated the public on their novel formulations and delivery method. “The Athens Cannabis Expo was an excellent opportunity for X-SPRAYS™ to network with EU cannabis businesses and to expand our European distribution channels,” said Mr. John Knapp, CEO of Integrated Cannabis. He goes on to say, “the European market showed us great promise in 2019 for CBD products. We are positioning ourselves to take full advantage of the changing landscape this year and believe Europe will be a pivotal component for our growth.” X-SPRAYS™ connected with dozens of businesses including pharmacies and specialty retailers all of which represented hundreds of retail outlets showing keen interest in carrying our product line. About Integrated Cannabis Company Integrated Cannabis Company, Inc. is comprised of dedicated scientists and product engineers who are passionate about health and creating health and lifestyle products utilizing advanced delivery systems and formulations. For more information, please visit the company’s website at: ON BEHALF OF THE BOARD “John Knapp” The CSE does not accept responsibility for the adequacy or accuracy of this release. Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. Related Articles

  • What is X-SPRAYS's latest funding round?

    X-SPRAYS's latest funding round is Acquired.

  • Who are the investors of X-SPRAYS?

    Investors of X-SPRAYS include CNRP Mining.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.